IT vs MRNA · P/E 16, rev $6.27B vs rev $1.94B
Gartner Inc (IT) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
IT currently screens at market cap $11.03B and trailing P/E 16.3. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the IT and MRNA stock pages for the full models.
Not investment advice.